Protective effect of Cnidoscolus aconitifolius leaves against diclofenac-induced gastric mucosal damage
Related Experiment Video
Updated: Dec 24, 2025

Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
Published on: March 1, 2024
Njoku Ugochi Olivia1, Uzoagulu Chinedu Happiness1, Ogugofor Martins Obinna1
1Pharmacology and Toxicology Unit, Department of Biochemistry, University of Nigeria, Nsukka, Nigeria.
Abstract:
Cnidoscolus aconitifolius is one of the plants used in folk medicine for the treatment of peptic ulcer. However, the present study was designed to validate the gastro-protective effect of Cnidoscolus aconitifolius leaves using diclofenac-induced ulcer model. The gastro-protective effect of Cnidoscolus aconitifolius leaves was evaluated by employing diclofenac-induced gastric ulcer in rats. Gastric mucosal lesions were induced by oral administration of diclofenac in rats. The pH of gastric juice from pylorus-ligated rats was measured. Histological examinations of the gastric tissues were also carried out. The present findings showed that Cnidoscolus aconitifolius leaf methanol extract exerted gastro-protective activity, as demonstrated by its consistent significant and dose dependent increase in mean ulcer index (MUI) inhibition against gastric mucosa damage induced by diclofenac treatment. Histological investigation of the gastric lesions showed that the plant stimulates the scarring cicatrizing process and thereby maintaining the architecture of the mucosal surfaces. The gastro-protective effect observed could be related to the therapeutic properties of the phytoconstituents of Cnidoscolus aconitifolius extract. Cnidoscolus aconitifolius leaves possess gastro-protective property in a dose dependent manner.
More Related Videos
08:34Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Related Concept Videos
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Drugs for Treatment of Ulcerative Colitis in IBD
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...